A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice

BACKGROUND: Although DAAs hold promise to significantly reduce rates of chronic HCV infections, its eradication still requires development of an effective vaccine. Prolonged T cell responses and cross neutralizing antibodies are ideal for vaccination against the infection. We aimed to design and syn...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Infect Dis
Autors principals: Dawood, Reham M., Moustafa, Rehab I., Abdelhafez, Tawfeek H., El-Shenawy, Reem, El-Abd, Yasmine, Bader El Din, Noha G., Dubuisson, Jean, El Awady, Mostafa K.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6833294/
https://ncbi.nlm.nih.gov/pubmed/31690267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-019-4571-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars